Companies / Egypt

Price Controls Hamper Growth

January 2007 | BMI View

Egypt's drug market was worth US$1.14bn in 2005 and is one of the largest in the Middle East and North Africa (MENA) region. However,

To read the full article, please sign in or take a free trial.

Related Insight Articles

Controversial Pricing Changes Suspended By Government

Industry / Egypt In late 2009, BMI analysed the drug pricing amendment put forward by the Egyptian government. The implications for the local and multinational drugmakers in the country were far-reaching and we cautioned...

May 2010

Taxing Other Sectors To Raise Funds For Ministry Of Health

Industry / Egypt Egypt's government-owned Medical Insurance Authority is trying to reduce its massive budget deficit of US$31.2mn by increasing the price of subscriptions from EGP4 (US$0.73) to EGP8 (US$1.46) per person....

April 2010

Drug Regulation To Be Strengthened

Industry / Egypt The Egyptian government believes that counterfeit drugs in the country could be worth around US$181mn. It also estimates that 10% of medicines found in otherwise legal pharmacies are actually fake. While...

April 2010

Government Allows Limited Drug Price Rises

Industry / Egypt Egypt's Ministry of Health and Population has bowed to pressure from manufacturers worried by rising raw material costs and agreed an 8% increase in the price of 265 drugs, representing 3.4% of the pharmaceuticals...

January 2008

Private Health Spending On Rise In Egypt

Companies / Egypt The Egyptian government is planning to establish 50 state hospitals using both local and foreign private sector financing, according to the country's Minister of Health. The project is scheduled for...

July 2006